Teva Pharmaceutical Industries Limited (TEVA)
Largest Insider Buys in Sector
TEVA Stock Price History Chart
TEVA Stock Performance
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it …
Insider Activity of Teva Pharmaceutical Industries Limited
Over the last 12 months, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $21.02M worth of Teva Pharmaceutical Industries Limited stock.
On average, over the past 5 years, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $10.75M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 209,000 shares for transaction amount of $2.01M was made by BARER SOL J (director) on 2019‑06‑04.
List of Insider Buy and Sell Transactions, Teva Pharmaceutical Industries Limited
| 2024-11-20 | Sale | EVP, Head of U.S. Commercial | 19,388 0.0017% | $16.87 | $327,085 | +0.53% | ||
| 2024-08-12 | Sale | Exec. VP, European Commercial | 98,943 0.0088% | $17.30 | $1.71M | +3.81% | ||
| 2024-08-09 | Sale | EVP, Business Development | 4,065 0.0004% | $17.28 | $70,243 | +1.69% | ||
| 2024-08-09 | Sale | See "Remarks" | 45,060 0.004% | $17.38 | $782,972 | +1.69% | ||
| 2024-08-01 | Sale | See "Remarks" | 24,537 0.0021% | $17.25 | $423,280 | +0.14% | ||
| 2024-06-18 | Sale | director | 519,000 0.045% | $17.03 | $8.84M | +2.73% | ||
| 2024-05-16 | Sale | Chief Accounting Officer | 12,635 0.0011% | $16.65 | $210,377 | +6.35% | ||
| 2024-05-15 | Sale | Chief Accounting Officer | 15,500 0.0014% | $16.80 | $260,417 | +3.28% | ||
| 2024-05-13 | Sale | See "Remarks" | 15,219 0.0013% | $16.74 | $254,807 | +2.37% | ||
| 2024-03-06 | Sale | EVP, Chief Financial Officer | 77,550 0.0069% | $13.52 | $1.05M | +24.94% | ||
| 2024-03-05 | Sale | EVP, International Markets | 100,000 0.0089% | $13.52 | $1.35M | +24.91% | ||
| 2024-03-05 | Sale | Exec. VP, European Commercial | 48,629 0.0043% | $13.52 | $657,240 | +24.91% | ||
| 2024-03-05 | Sale | See "Remarks" | 1,427 0.0001% | $13.52 | $19,286 | +24.91% | ||
| 2024-03-04 | Sale | President and CEO | 31,061 0.0028% | $13.34 | $414,270 | +25.71% | ||
| 2024-03-04 | Sale | Exec. VP, European Commercial | 33,512 0.003% | $13.34 | $446,960 | +25.71% | ||
| 2024-03-04 | Sale | See "Remarks" | 8,045 0.0007% | $13.34 | $107,299 | +25.71% | ||
| 2024-03-04 | Sale | See "Remarks" | 3,532 0.0003% | $13.37 | $47,235 | +25.71% | ||
| 2024-02-28 | Sale | Exec. VP, European Commercial | 20,599 0.0018% | $13.12 | $270,176 | +28.95% | ||
| 2024-02-28 | Sale | Executive VP Global Operations | 9,815 0.0009% | $13.12 | $128,734 | +28.95% | ||
| 2024-02-28 | Sale | See "Remarks" | 1,366 0.0001% | $13.12 | $17,916 | +28.95% |
Insider Historical Profitability
| MIGNONE ROBERTO | director | 981000 0.0865% | $22.09 | 2 | 1 | +9.88% |
| BARER SOL J | director | 220442 0.0194% | $22.09 | 2 | 0 | +0.5% |
| Dethlefs Sven | EVP, North America Commercial | 165381 0.0146% | $22.09 | 1 | 17 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $616.67M | 3.86 | 43.7M | +4.89% | +$28.78M | 0.01 | |
| ION Asset Management | $544.34M | 3.41 | 38.58M | -4.34% | -$24.68M | 39.63 | |
| Phoenix Holdings Ltd | $488.08M | 3.05 | 34.58M | +0.58% | +$2.8M | 6.78 | |
| Migdal Insurance Financial Holdings Ltd | $421.29M | 2.64 | 29.86M | +3.24% | +$13.24M | 6.89 | |
| Clal Insurance Enterprises Holdings Ltd | $406.06M | 2.54 | 28.79M | -12.22% | -$56.55M | 4.71 |